bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.14.759250

Engineering potent avian GPR25 agonists using an ostrich CXCL17 gene relic

Abstract

C-X-C motif chemokine ligand 17 (CXCL17) activates G protein-coupled receptor 25 (GPR25) in most vertebrate lineages. Although birds appear to have lost functional CXCL17, CXCL17 gene relics and intact GPR25 genes persist in certain taxa. This study investigated whether a fragment encoded by an avian CXCL17 gene relic could guide the engineering of potent agonists for avian GPR25s. A 22-residue C-terminal fragment encoded by African ostrich CXCL17 gene relic was grafted onto the corresponding position of loggerhead turtle or human CXCL17, and the resulting hybrids were prepared via bacterial overexpression and functionally characterized via cell-based assays. The turtle-ostrich and human-ostrich CXCL17 hybrids showed no detectable activity at turtle or human GPR25 but exhibited substantially greater potency than their parental proteins at two avian GPR25s in {beta}-arrestin recruitment assays, with half-maximal effective concentrations of approximately 25 and 100 nM at the ostrich receptor and 5 and 13 nM at the mallard receptor, respectively. Both hybrids bound directly to the ostrich or mallard GPR25 in homogenous ligand-receptor binding assays and induced migration of transfected cells expressing the ostrich or mallard receptor in chemotaxis assays. These findings demonstrate that a fragment encoded by the ostrich CXCL17 gene relic confers potent avian GPR25 agonism and establishes the C-terminus as the primary driver of species selectivity. These hybrids provide functional surrogate tools for probing avian GPR25 biology.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yu, J., Li, H.-Z., Wang, J.-J., Liu, Y.-L., Guo, Z.-Y.. 2026-10-16. Engineering potent avian GPR25 agonists using an ostrich CXCL17 gene relic. https://doi.org/10.64898/2026.10.14.759250

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Investigating Histone Lysine Acetylation and Acetyl-methylation in Mouse Brain using Enhanced Trimethylacetic Anhydride Derivatization Protocol

Histone post-translational modifications (PTMs) are key regulators of gene expression, and mass spectrometry (MS) provides a powerful platform for their characterization and quantification. However, conventional histone sample preparation using derivatization of non-modified lysines by propionic anhydride (PA) presents analytical limitations, including non-detection of short hydrophilic peptides, incomplete chromatographic separation of positional isomers, and masking of endogenous lysine propionylation and butyrylation. Here, we optimized a trimethylacetic anhydride (TMA)-based derivatization workflow to improve histone PTM analysis. Compared with PA derivatization, TMA enhanced the detection of acetylated peptides, particularly short and hydrophilic species, although peptide-dependent ionization biases affected relative peptidoform quantification. We further evaluated the suitability of TMA derivatization for investigating endogenous lysine propionylation and butyrylation. Unexpectedly, we identified lysine acetyl-methylation (Kacme) at seven sites on histone H3 and validated these assignments by targeted MS using synthetic reference peptides. To investigate the metabolic dynamics of Kacme, we performed in vivo isotope tracing in mice administered 13C-labeled glucose. Unlike canonical lysine acetylation, Kacme exhibited minimal incorporation of glucose-derived acetyl groups over 2h, suggesting substantially slower turnover of its acetyl moiety. Collectively, these findings highlight the analytical advantages and quantitative limitations of TMA-based histone derivatization, while revealing Kacme as a metabolically distinct histone modification and expanding the scope of MS-based histone PTM analysis.

biochemistry↗

Bivalent Inhibitor Development for a Dynamic Epigenetic Tandem Reader Protein Using a Combinatorial Histone Code

Epigenetic readers are a class of proteins that recognize specific chemical modifications on histones to differentially regulate gene expression. Aberrant expression of readers can drive the progression of many diseases and cancers, making this protein class viable therapeutic targets. Understanding the landscape of histone modifications recognized by reader domains, and the structural mechanisms that drive these molecular recognition events, is crucial for guiding the design of pharmaceutically relevant chemical probes. BPTF contains a plant homeodomain (PHD) finger and tandem bromodomain (BRD). Here, we expand upon previous studies that found the BPTF BRD can engage acetyllysine modifications on the N-terminus of histone H3. We uncover H3K4me3K14ac as the specific modifications recognized by the PHD BRD cassette, which is confirmed by crystallography. Using orthogonal methods, our work explores how these modifications can be read cooperatively, including in cis. We report the first experimental evidence proposing a ligand-induced conformational change between the two reader domains of BPTF, supporting previous computational approaches that have predicted a macromolecular rearrangement. We leverage these structural insights to rationally design a peptide-small molecule conjugate MJ-1 that inhibits both domains of BPTF and overcomes ligandability challenges associated with PHD-finger-containing proteins. The results presented here elucidate the molecular basis of the bivalent recognition of multiply modified histone H3 by BPTF and provide structural insight for developing compounds targeting the PHD finger of BPTF for therapeutic applications.

biochemistry↗

Binding of a Macrocyclic Nonapeptide Inhibitor to Histone Deacetylase 6

Histone deacetylase 6 (HDAC6) plays an essential role in the regulation of post-translational lysine acetylation. Myriad biological processes depend on the precise regulation of lysine acetylation-deacetylation cycles, and their dysregulation is linked to human pathologies such as cancer and neurodegeneration. Broad-specificity HDAC inhibitors are efficacious in treating disease, but the inhibitors currently approved for clinical use often cause deleterious side effects due to inhibition of multiple HDAC isozymes as well as other zinc enzymes. Cyclic peptides comprise novel platforms that, in principle, can be tailored for affinity and selectivity. A key advantage of cyclic peptide design is the ability to incorporate both canonical and noncanonical amino acids. As part of our program focusing on cyclic peptide HDAC inhibitors, we now report the 1.9-[A] resolution crystal structure of HDAC6 CD2 complexed with macrocyclic nonapeptide 1. The structure reveals zinc coordination by a noncanonical thiolate-containing amino acid, plus direct and water-mediated enzyme-inhibitor hydrogen bonds that contribute to nanomolar inhibitory potency. Structural comparisons with previously reported HDAC6 CD2 complexes with tetrapeptide and octapeptide macrocycles reveal similar networks of direct and water-mediated interactions. Given the surge of interest in cyclic peptide inhibitors, fueled in part by advances in computational design approaches, the crystal structure of the HDAC6 CD2-1 complex sets an important foundation for further development of macrocyclic peptide inhibitors.

biochemistry↗